Virginia Tech® home

Annual Health Sciences and Technology Hokie Pitch

Insert your title here

students pitch ideas

Shark tank pitch
During the shark-tank style competition, student teams eventually pitch ideas and answer questions from judges, as illustrated by this photo from a previous competition at the Fralin Biomedical Research Institute at VTC.

Fall 2021 HS&T Hokie Pitch

Dec. 8, 2021 

2:30 p.m. to 4:00 p.m.

How to attend:  Viewers can watch the live webcast.

Contact Linda Collins for more details.

About the event

Virginia Tech students will pitch biomedical commercialization ideas to a “shark tank”-style panel of judges at 2:30 p.m. on Wednesday, Dec. 8, during the Health Sciences and Technology (HS&T) Hokie Pitch.

The competition will involve graduate students who have worked with real-world mentors, selected intellectual property, and created an entrepreneurial plan to develop and commercialize biomedical discoveries. Viewers can watch the live webcast of the teams making their pitches beginning at 2:30 p.m. Wednesday.

The competition involves five teams of Virginia Tech students in the Translational Biology, Medicine, and Health (TBMH) graduate program. The students will compete for $4,000 in cash prizes. The competition is sponsored by the Fralin Biomedical Research Institute, Carilion Clinic, Woods Rogers law firm and Fralin Biomedical Research Institute advisory board member Maria Clarke of J.P. Morgan Private Bank.

You May Also Be Interested In...

  • Home Item
    Social Learning in Borderline Personality Disorder
    Social Learning in Borderline Personality Disorder , home

    April 4, 2025, 11:00 a.m. | Sarah Fineberg, M.D., Ph.D., Assistant Professor, Department of Psychiatry, Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research

  • Home Item
    Bringing Precision Medicine to Psychiatry
    Bringing Precision Medicine to Psychiatry , home

    April 10, 2025, 5:30 p.m. (Reception at 5 p.m.) | Jordan Smoller, M.D., Sc.D., MGH Trustees Endowed Chair in Psychiatric Neuroscience; Professor of Psychiatry, Harvard Medical School; Professor of Epidemiology, T.H. Chan Harvard School of Public Health; Director, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital | Maury Strauss Distinguished Public Lecture

  • Home Item
    Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart
    Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart , home

    April 11, 2025, 11:00 a.m. | Susmita Sahoo, Ph.D., Associate Professor, Department of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    A Human-Centric View of Cerebellar Development
    A Human-Centric View of Cerebellar Development , home

    April 18, 2025, 11:00 a.m. | Kathleen Millen, Ph.D., Professor, Department of Pediatrics/Genetics, Associate Director and Principal Investigator, Seattle Children's Hospital Research Institute, The University of Washington School of Medicine | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute

  • Home Item
    Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders
    Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , home

    May 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture

  • Home Item
    A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
    A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , home

    May 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke